[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620653":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":28,"responsibleParty":46,"collaborators":48,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":53,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":71,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Applied Biologics, LLC","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"OneStep Foot Scanner",null,"This study is a follow-up durability trial from the CAMPX randomized controlled clinical trial. Only subjects who achieved complete closure at 12 weeks in the CAMPX trial will be evaluated. After signing the IRB-approved informed consent form, the subject will receive instruction on the BlueDrop® OneStep Foot Scanner™. In addition, written instructions on use will be provided. Subjects that are unable to use the scale will be asked to answer a questionnaire at 3, 6, 9, and 12 months after signing the consent form.",[13],"Other: Blue Drop Foot Scanner",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","Blue Drop Foot Scanner","Subjects with eligible wound will receive a BlueDrop® OneStep Foot Scanner™. They are instructed to step on the scale each morning. The Bluetooth technology transmits a photograph and thermal image to the central monitoring nurse at BlueDrop®. All information transmitted is compliant with HIPPA regulations. Subjects that are unable to use the scale will receive a phone call at months 3,6, 9 and 12 months to determine if the foot has remained closed.",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Bennett Sarver","CONTACT","1-833-865-6300","info@serenagroups.com",{"name":27,"role":23,"phone":24,"phoneExt":10,"email":25},"Thomas Serena, MD",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Detroit Foot and Ankle","RECRUITING","Clinton Township","Michigan","48038","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-82.91992,42.58698,{"lat":41,"lon":40},[44],{"name":45,"role":23,"phone":10,"phoneExt":10,"email":10},"Lina Barman",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[49],{"name":50,"class":16},"Serena Group","100620653","evaluating-the-durability-of-closure-for-diabetic-foot-ulcers-following-a-randomized-controlled-modified-platform-trial-100620653",false,"NCT07360418","Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.","A Prospective Multicenter Study Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial","SCANX","Inclusion Criteria:\n\n* The potential subject must have participated in the CAMPX trial and achieved complete closure by the 12-week endpoint.\n\nExclusion Criteria:\n\n* The potential subject did not participate in the CAMPX trial.\n* The potential subject participated in the CAMPX trial and did not achieve complete closure.","ALL","18 Years",{"count":62,"type":63},50,"ESTIMATED","OBSERVATIONAL","Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.",[67,68,69,70],"Diabetic Foot Ulcers (DFU)","Foot Ulcer Chronic","Ulcer","Diabetic Foot Ulcer",[72,73,74,75],"CAMPX","CAMP","Foot Ulcer","diabetic foot ulcer","2026-02-09",{"date":78,"type":79},"2026-02-10","ACTUAL",{"date":81,"type":79},"2025-10-16",{"date":83,"type":63},"2027-10",{"name":5,"class":6},1]